Yuyu Pharma, Inc. (000225.KS) KSC
4,275.00
+5(+0.12%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
4,275.00
+5(+0.12%)
Currency In KRW
| Market Cap | 74.91B |
| Enterprise Value | 73.74B |
| P/E Ratio | 8.33 |
| PEG Ratio | 0.29 |
| Price/Sales Ratio | 0.47 |
| Price/Book Ratio | 0.5 |
| Enterprise/Revenue | 0.46 |
| Enterprise/EBITDA | 3.93 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | 0.06 |
| Operating Margin | 0.08 |
| Return On Assets | 0.04 |
| Return On Equity | 0.06 |
| Revenue | 140.88B |
| Revenue/Share | 8,898.17 |
| Gross Profit | 53.94B |
| EBITDA | 16.63B |
| Net Income | 7.8B |
| Diluted EPS | 463 |
| Total Cash | 29.09B |
| Total Cash/Share | 1,837.35 |
| Total Debt | 27.92B |
| Total Debt/Equity | 0.22 |
| Current Ratio | 1.64 |
| Book Value Per Share | 8,854.16 |
| 52-Week Change | -10.56 |
| 52-Week High | 5,700 |
| 52-Week Low | 4,180 |
| Moving Average 50 Days | 4,610.3 |
| Moving Average 200 Days | 4,817.95 |
| Average Volume | 21,836 |
| Shares Outstanding | 16.57M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 100 |
| Trailing Annual Dividend Yield | 2.44 |
| Payout Ratio | 0.25 |
| Last Split Factor | 2:1 |
| Last Split Date | March 30, 2021 |